Evidence map›Paper›PMID 27232940›Full record

ArticleOncotarget2016

Associations between genetic variants located in mature microRNAs and risk of lung cancer.

Dengrui Li, Guiyun Zhu, Hongqin Di, Hui Li, Xinyan Liu, Min Zhao, Zhihua Zhang, Yonghui Yang

Abstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dengrui LiDepartment of General Internal Medicine, Chest Hospital of Hebei Province, Lung Cancer Prevention and Control Center of Hebei Province, Shijiazhuang, Hebei, China, 050041.
Guiyun ZhuDepartment of Pathology, Chest Hospital of Hebei Province, Lung Cancer Prevention and Control Center of Hebei Province, Shijiazhuang, Hebei, China, 050041.
Hongqin DiClinical Laboratory, Chest Hospital of Hebei Province, Lung Cancer Prevention and Control Center of Hebei Province, Shijiazhuang, Hebei, China, 050041.
Hui LiDepartment of Thoracic Surgery, Chest Hospital of Hebei Province, Lung Cancer Prevention and Control Center of Hebei Province, Shijiazhuang, Hebei, China, 050041.
Xinyan LiuThe First Department of Oncology, Chest Hospital of Hebei Province, Lung Cancer Prevention and Control Center of Hebei Province, Shijiazhuang, Hebei, China, 050041.
Min ZhaoThe Second Department of Oncology, Chest Hospital of Hebei Province, Lung Cancer Prevention and Control Center of Hebei Province, Shijiazhuang, Hebei, China, 050041.
Zhihua ZhangMedical Department, Chest Hospital of Hebei Province, Lung Cancer Prevention and Control Center of Hebei Province, Shijiazhuang, Hebei, China, 050041.
Yonghui YangDepartment of Pathology, Chest Hospital of Hebei Province, Lung Cancer Prevention and Control Center of Hebei Province, Shijiazhuang, Hebei, China, 050041.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MiRNAs have been focused for their wide range of biological regulatory functions. Previous studies have suggested that individual miRNAs could influence tumorigenesis through their regulation of specific proto-oncogenes and tumor suppressor genes. This study was implemented to investigate the associations between SNPs in mature microRNAs (miRNAs) and development of lung cancer in a two-stage, case-control study, followed by some functional validations. First, 11 SNPs were analyzed in a case-control study of lung cancer, and the significant results were validated in an additional population. Our results showed that rs3746444 in mir-499 (allele C vs T: OR = 1.33; 95% CI = 1.15-1.54; P = 1.2 × 10-4) and rs4919510 in mir-608 (allele G vs C: OR = 1.27; 95% CI= 1.13-1.43; P = 5.1 × 10-5) were significantly associated with increased risk of lung cancer. Rs3746444 in mir-499 was also significantly associated with poor survival of lung cancer (HR, 1.35; 95% CI, 1.15-1.58; P = 0.0002). The expression levels of mir-499 and mir-608 were significantly lower than those of adjacent normal tissues (P < 0.0005), and the carriers of minor alleles have lower expression levels of mir-499 and mir-608 than those of major alleles (P < 0.001). These findings indicated that rs3746444 in mir-499 and rs4919510 in mir-608 might play a substantial role in the susceptibility to lung cancer.

Indexed as

Polymorphism, Single NucleotideAgedAllelesCarcinoma, Non-Small-Cell LungCase-Control StudiesFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHumansLung NeoplasmsMaleMicroRNAsMiddle AgedRisk FactorsRNA Processing, Post-TranscriptionalSmall Cell Lung CarcinomaMicroRNAslung cancermicroRNAsvariant

Identifiers

PMID27232940
PMCPMC5173090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.